Merck Tells Fed. Circ. Antibiotic Obvious Only In 'Hindsight'
Merck urged a Federal Circuit panel in oral arguments Monday to upend the invalidation of an antibiotic patent it accuses Hospira of infringing, contending the district court could only have determined...To view the full article, register now.
Already a subscriber? Click here to view full article